Brief: Titan Pharmaceuticals To Explore Strategic Alternatives
21/12/2021 13:14
Dec 21 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS TO EXPLORE STRATEGIC ALTERNATIVES
* TITAN PHARMACEUTICALS INC - TITAN HAS ENGAGED MAXIM GROUP
LLC AS
ITS EXCLUSIVE FINANCIAL ADVISOR TO ASSIST IN THIS PROCESS
* TITAN PHARMACEUTICALS INC - STRATEGIC ALTERNATIVES THAT
MAY BE
EXPLORED OR EVALUATED INCLUDE ACQUISITION, MERGER, REVERSE
MERGER
* TITAN PHARMA - STRATEGIC ALTERNATIVES INCLUDE OTHER
BUSINESS
COMBINATION, SALES OF ASSETS, LICENSING/OTHER STRATEGIC
TRANSACTIONS INVOLVING COMPANY
Source text for Eikon: ID:nPn9XKs5da
Further company coverage: TTNP.O
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.